Leif Rune Skymoen er administrerende direktør i Legemiddelindustrien (LMI), som er bransjeforeningen for legemiddelindustrien i Norge. Skymoen er utdannet farmasøyt fra UiO med hovedfagsår ved University of Oxford, og har en Executive Master of Management fra BI. Han har lang erfaring fra ulike lederroller i legemiddelindustri og klynger, inkludert 8 år som CEO i Curida. Fra 2002 til 2012 jobbet han i Eli Lilly – blant annet som daglig leder i Norge. Han har også vært CEO for Nansen Neuroscience Network, og har styreerfaring en rekke selskaper og organisasjoner. Skymoen tok over lederjobben i LMI etter Karita Bekkemellem 1. mars 2023.
Leif Rune Skymoen is the CEO of Legemiddelindustrien (LMI), the trade association for the pharmaceutical industry in Norway.
Skymoen holds a degree in pharmacy from the University of Oslo, including a final-year research placement at the University of Oxford. He also holds an Executive Master of Management from BI Norwegian Business School.
He has extensive experience from various leadership roles in the pharmaceutical industry and innovation clusters, including eight years as CEO of Curida. From 2002 to 2012, he worked at Eli Lilly — including serving as Managing Director for the Norwegian operations.
He has also been CEO of the Nansen Neuroscience Network and has board experience from a wide range of companies and organizations.
Skymoen took over as CEO of LMI on 1 March 2023.